Clinical trial information as a measure of quality cancer care

Journal of Oncology Practice

Volumn 6, Issue 3, 2010, Pages 170-171

  Chua, Wei ^a   Clarke, Stephen J ^a  

^a ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RESEARCH; CANCER STAGING; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COLORECTAL CARCINOMA; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; LUNG NON SMALL CELL CANCER; MEDICAL INFORMATION; ONCOLOGIST; ONCOLOGY; PHYSICIAN; POPULATION SIZE; PRACTICE GUIDELINE; PROSPECTIVE PAYMENT; QUALITY OF LIFE; SHORT SURVEY; TESTIS CANCER;

EID: 77956570796     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.091099     Document Type: Short Survey

References (14)

1. Neuss MN, Desch CE, McNiff KK, et al: A process for measuring the quality of cancer care: The Quality Oncology Practice Initiative. J Clin Oncol 23:6233-6239, 2005
2. Schneider EC, Malin JL, Kahn KL, et al: Developing a system to asses the quality of cancer care: ASCO's National Initiative on Cancer Care Quality. J Clin Oncol 22:2985-2991, 2004
3. McNiff K: The Quality Oncology Practice Initiative. J Oncol Pract 2:26-30, 2006
4. Cancer Care Quality Measures: Diagnosis and Treatment of Colorectal Cancer - Evidence Report/Technology Assessment Number 138. http://www.ahrq.gov/ downloads/pub/evidence/pdf/colocanqm/colocanqm.pdf
5. Davis S, Wright PW, Schulman SF, et al: Participants in prospective, randomised clinical trials for resected non-small cell lung cancer have improved survival compared with non participants in such trials. Cancer 56:1710-1718, 1985
6. Mayers C, Panzarella T, Tannock IF: Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma. Cancer 91:2246-2257, 2001
7. Marubini E, Mariani L, Salvadori B, et al: Results of a breast-cancer-surgery trial compared with observational data from routine practice. Lancet 347:1000-1003, 1996
8. Feuer EJ, Frey CM, Brawley OW, et al: After a treatment breakthrough: A comparison of trial and population- based data for advanced testicular cancer. J Clin Oncol 12:368-377, 1994
9. Sorbye H, Pfeiffer P, Cavalli-Bjorkman N, et al: Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. Cancer 115:2679-2687, 2009
10. Zon R, Meropol NJ, Catalano RB, et al: American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites. J Clin Oncol 26:1-6, 2008
11. American Federation of Clinical Oncologic Societies: Access to quality cancer care: Consensus statement. J Clin Oncol 16:1628-1630, 1998
12. ASCO-ESMO consensus statement on quality cancer care. J Clin Oncol 24:3498-3499, 2006
13. National Health and Medical Research Council: Guidelines for the prevention, early detection and management of colorectal cancer 1999. http://www.nhmrc.gov.au/publications/synopses/cp62syn.htm
14. Armstrong K, O'Connell DL, Leong D, et al (eds): The New South Wales Colorectal Cancer Care Survey Part 2: Chemotherapy Management. Kings Cross, New South Wales, Australia, The Cancer Council NSW, 2005